首页> 美国卫生研究院文献>Scientific Reports >A novel cell membrane affinity sample pretreatment technique for recognition and preconcentration of active components from traditional Chinese medicine
【2h】

A novel cell membrane affinity sample pretreatment technique for recognition and preconcentration of active components from traditional Chinese medicine

机译:一种新的细胞膜亲和力样品预处理技术用于中药中有效成分的识别和富集

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe a novel biomembrane affinity sample pretreatment technique to quickly screen and preconcentrate active components from traditional Chinese medicine (TCM), which adopts cell membrane coated silica particles (CMCSPs) as affinity ligands which benefit the biomembrane’s ability to maximize simulation of drug-receptor interactions in vivo. In this study, the prepared CMCSPs formed by irreversible adsorption of fibroblast growth factor receptor 4 (FGFR4) cell membrane on the surface of silica were characterized using different spectroscopic and imaging instruments. Drug binding experiments showed the excellent adsorption rate and adsorption capacity of FGFR4/CMCSPs compared with non-coated silica particles. The FGFR4/CMCSPs were used as solid-phase extraction sorbents to pretreat the TCM Aconitum szechenyianum Gay. The resultant FGFR4/CMCSPs exhibited good performance. In addition, high selectivity and recognition ability of the FGFR4/CMCSPs were determined by selectivity experiments. Four alkaloid were screened and identified, one of these alkaloid, napellonine, showed favorable anti-tumor activity in preliminary pharmacological verification trials including cell proliferation and molecular docking assays. The proposed cell membrane affinity sample pretreatment method is a reliable, effective and time-saving method for fast screening and enriching active compounds and can be extended to pretreat other TCMs as leading compounds resources.
机译:我们描述了一种新型的生物膜亲和样品预处理技术,可以快速筛选和预浓缩中药(TCM)中的活性成分,该技术采用细胞膜包被的二氧化硅颗粒(CMCSP)作为亲和配体,这有利于生物膜最大程度地模拟药物-受体相互作用的能力体内。在这项研究中,通过使用不同的光谱和成像仪器来表征由成纤维细胞生长因子受体4(FGFR4)细胞膜在二氧化硅表面上的不可逆吸附所形成的CMCSP。药物结合实验表明,与未包覆的二氧化硅颗粒相比,FGFR4 / CMCSPs具有出色的吸附速率和吸附能力。 FGFR4 / CMCSPs被用作固相萃取吸附剂来预处理中药乌头盖伊。所得的FGFR4 / CMCSPs表现出良好的性能。另外,通过选择性实验确定了FGFR4 / CMCSP的高选择性和识别能力。筛选并鉴定出四种生物碱,其中一种生物碱,萘啶酮,在包括细胞增殖和分子对接测定在内的初步药理验证试验中显示出良好的抗肿瘤活性。所提出的细胞膜亲和力样品预处理方法是一种可靠,有效且省时的方法,可以快速筛选和富集活性化合物,并且可以扩展为预处理其他中药作为领先的化合物资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号